1-3 of 3
Francesca Sassolini, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment with Erythropoietic Stimulating Agents in IPSS Lower Risk MDS: Outcome Comparison Between 5q- and Non 5q- MDS Cases

Alessandro Sanna, MD, Roberto Latagliata, Daniela Gioia, Antonella Gozzini, MD, Francesca Sassolini, MD, Giuliana Alimena, MD, Alessandro Levis, MD, Alberto Bosi, MD, Valeria Santini, MD
Journal: Blood
Blood (2011) 118 (21): 2799.
https://doi.org/10.1182/blood.V118.21.2799.2799
Published: 2011
Journal Articles

Decitabine Treatment in Higher Risk MDS, CMML and AML Post-MDS Who Failed Azacitidine

Alessandro Sanna, MD, Antonella Gozzini, MD, Francesca Sassolini, MD, Alberto Bosi, MD, Valeria Santini, MD
Journal: Blood
Blood (2011) 118 (21): 5052.
https://doi.org/10.1182/blood.V118.21.5052.5052
Published: 2011
Journal Articles

Comorbidities Indexes In Patients Treated with 5-Azacitidine Are a An Useful and Easily Applicable Tool to Refine Prognostic Evaluation

Alessandro Sanna, MD, Laura Cannella, MD, Antonella Gozzini, MD, Massimo Breccia, MD, Francesca Sassolini, MD, Alberto Bosi, MD, Giuliana Alimena, MD, Valeria Santini, MD
Journal: Blood
Blood (2010) 116 (21): 606.
https://doi.org/10.1182/blood.V116.21.606.606
Published: 2010